Standout Papers

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a r... 1999 2026 2008 2017 786
  1. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial (1999)
    A.M. Snelling, D M Chalmers et al. The Lancet

Citation Impact

2 by Nobel laureates 39 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

The microbiome and human cancer
2021 StandoutScience
The microbiome and innate immunity
2016 StandoutNature
2 intermediate papers

Works of D M Chalmers being referenced

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
1999 Standout

Author Peers

Author Surgery Epidemiology PRM Molecular Biology Genetics Last Decade Papers Cites
D M Chalmers 587 325 475 552 523 30 1.9k
J. W. Shon 18 602
P. C. M. Boers 1 8 4 41 1.3k
Alexandra Deters 83 56 32 305 20 31 1.5k
Ulla Bjerre 161 30 16 80 174 8 608
Paul Pfaffenbichler 2 29 346

All Works

Loading papers...

Rankless by CCL
2026